Increased homocysteine, homocysteine-thiolactone, protein homocysteinylation and oxidative stress in the circulation of patients with Eales' disease

Annals of Clinical Biochemistry

Volumn 50, Issue 4, 2013, Pages 330-338

  Bharathselvi, Muthuvel ^a   Biswas, Jyothirmay ^b   Selvi, Radhakrishnan ^a   Coral, Karunakaran ^a   Narayanasamy, Angayarkanni ^a   Ramakrishnan, Sivaramakrishnan ^a   Sulochana, Konerirajapuram N ^a  

^a VISION RESEARCH FOUNDATION   (India)

^b MEDICAL RESEARCH FOUNDATION   (India)

Author keywords

Clinical studies; Laboratory methods; Statistics

Indexed keywords

COPPER; GLUTATHIONE; HOMOCYSTEINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOLACTONE;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONJUGATION; CONTROLLED STUDY; COPPER BLOOD LEVEL; EALES DISEASE; HUMAN; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN HOMOCYSTEINYLATION; PROTEIN MODIFICATION;

EID: 84890189200     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1177/0004563213492146     Document Type: Article

References (48)

1. Eales H. Retinal hemorrhages associated with epistaxis and constipation. Brim Med Rev 1888; 9: 262-5.
2. Puttamma. Varied fundus picture of peripheral retinal vasculitis. Trans Asia Pacific Acad Opthalmol 1970; 3: 520-5.
3. Saxena S and Kumar D. A new staging system for idiopathic retinal periphlebitis. Eur J Ophthalmol 2004; 14: 236-9.
4. Atabay C, Erdem E, Kansu T and Eldem B. Eales disease with internuclear ophthalmoplegia. Ann Ophthalmol 1992; 24: 267-9.
5. Ramakrishnan S, Rajesh M and Sulochana KN. Eales' disease: oxidant stress and weak antioxidant defence. Indian J Ophthalmol 2007; 55: 95-102.
6. Ueland PM, Nygard O, Vollset SE and Refsum H. The Hordaland homocysteine studies. Lipids 2001; 36: S33-9.
7. McDowell IF and Lang D. Homocysteine and endothelial dysfunction: a link with cardiovascular disease. J Nutr 2000; 130: 369S-372S.
8. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969; 56: 111-28.
9. Lominadze D, Roberts AM, Tyagi N, Moshal KS and Tyagi SC. Homocysteine causes cerebrovascular leakage in mice. Am J Physiol Heart Circ Physiol 2006; 290: H1206-13.
10. Lieberman TW, Podos SM and Hartstein J. Acute glaucoma, ectopia lentis and homocystinuria. Am J Ophthalmol 1966; 61: 252-5.
11. Roedl JB, Bleich S, Reulbach U, et al. Homocysteine in tear fluid of patients with pseudoexfoliation glaucoma. J Glaucoma 2007; 16: 234-9.
12. Stanger O, Weger M, Obeid R, et al. Impairment of homocysteine metabolism in patients with retinal vascular occlusion and non-arteritic ischemic optic neuropathy. Clin Chem Lab Med 2005; 43: 1020-5.
13. Coral K, Raman R, Rathi S, et al. Plasma homocysteine and total thiol content in patients with exudative agerelated macular degeneration. Eye (Lond) 2006; 20: 203-7.
14. Narayanasamy A, Subramaniam B, Karunakaran C, et al. Hyperhomocysteinemia and low methionine stress are risk factors for central retinal venous occlusion in an Indian population. Invest Ophthalmol Vis Sci 2007; 48: 1441-6.
15. Brazionis L, Rowley K Sr, Itsiopoulos C, Harper CA and O'Dea K. Homocysteine and diabetic retinopathy. Diabetes Care 2008; 31: 50-6.
16. Jakubowski H. Pathophysiological consequences of homocysteine excess. J Nutr 2006; 136: 1741S-1749S.
17. Jakubowski H. Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels. FASEB J 1999; 13: 2277-83.
18. Jakubowski H and Goldman E. Editing of errors in selection of amino acids for protein synthesis. Microbiol Rev 1992; 56: 412-29.
19. Jakubowski H. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease. J Physiol Pharmacol 2008; 59: 155-67.
20. Hughes WM Jr, Rodriguez WE, Rosenberger D, et al. Role of copper and homocysteine in pressure overload heart failure. Cardiovasc Toxicol 2008; 8: 137-44.
21. Devasagayam TP and Tarachand U. Decreased lipid peroxidation in the rat kidney during gestation. Biochem Biophys Res Commun 1987; 145: 134-8.
22. Hu ML. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 1994; 233: 380-5.
23. Rajesh M, Ramesh A, Ravi PE, et al. Accumulation of 8- hydroxydeoxyguanosine and its relationship with antioxidant parameters in patients with Eales' disease: implications for antioxidant therapy. Curr Eye Res 2003; 27: 103-10.
24. Jakubowski H, Zhang L, Bardeguez A and Aviv A. Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis. Circ Res 2000; 87: 45-51.
25. Coral K, Angayarkanni N, Gomathy N, Bharathselvi M, Pukhraj R and Rupak R. Homocysteine levels in the vitreous of proliferative diabetic retinopathy and rhegmatogenous retinal detachment: its modulating role on lysyl oxidase. Invest Ophthalmol Vis Sci 2009; 50: 3607-12.
26. Jakubowski H. The determination of homocysteine-thiolactone in biological samples. Anal Biochem 2002; 308: 112-19.
27. Chwatko G and Jakubowski H. The determination of homocysteine-thiolactone in human plasma. Anal Biochem 2005; 337: 271-7.
28. Ramakrishnan S, Sulochana KN, Selvaraj T, Abdul Rahim A, Lakshmi M and Arunagiri K. Smoking of beedies and cataract: cadmium and vitamin C in the lens and blood. Br J Ophthalmol 1995; 79: 202-6.
29. Klevay LM. Ischemic heart disease as deficiency disease. Cell Mol Biol 2004; 50: 877-84.
30. Rao NA and Wu GS. Free radical mediated photoreceptor damage in uveitis. Prog Retin Eye Res 2000; 19: 41-68.
31. Anderson RE, Maude MB, Narfstrom K and Nilsson SE. Lipids of plasma, retina, and retinal pigment epithelium in Swedish briard dogs with a slowly progressive retinal dystrophy. Exp Eye Res 1997; 64: 181-7.
32. Fliesler SJ and Anderson RE. Chemistry and metabolism of lipids in the vertebrate retina. Prog Lipid Res 1983; 22: 79-131.
33. Mates JM, Perez-Gomez C and Nunez de Castro I. Antioxidant enzymes and human diseases. Clin Biochem 1999; 32: 595-603.
34. Thomas EL, Learn DB, Jefferson MM and Weatherred W. Superoxide-dependent oxidation of extracellular reducing agents by isolated neutrophils. J Biol Chem 1988; 263: 2178-86.
35. Sulochana KN, Biswas J and Ramakrishnan S. Eales' disease: increased oxidation and peroxidation products of membrane constituents chiefly lipids and decreased antioxidant enzymes and reduced glutathione in vitreous. Curr Eye Res 1999; 19: 254-9.
36. Jakubowski H. Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation. J Biol Chem 2000; 275: 3957-62.
37. Watanabe ENY. Homocysteine as a modulator of platelet- derived growth factor action in vascular smooth muscle cells: a possible role for hydrogen peroxide. Br J Pharmacol 1997; 122: 269-74.
38. Liu G, Nellaiappan K and Kagan HM. Irreversible inhibition of lysyl oxidase by homocysteine thiolactone and its selenium and oxygen analogues. Implications for homocystinuria. J Biol Chem 1997; 272: 32370-7.
39. Ferguson EPS, Joseph J and Kalyanaraman B. Generation and initial characterization of a novel polyclonal antibody directed against homocysteine thiolactone- modified low density lipoprotein. J Lipid Res 1997; 4: 925-33.
40. Najib S and Sanchez-Margalet V. Homocysteine thiolactone inhibits insulin signaling, and glutathione has a protective effect. J Mol Endocrinol 2001; 27: 85-91.
41. Linnebank M, Lutz H, Jarre E, et al. Binding of copper is a mechanism of homocysteine toxicity leading to COX deficiency and apoptosis in primary neurons, PC12 and SHSY-5Y cells. Neurobiol Dis 2006; 23: 725-30.
42. Brown JC and Strain JJ. Effect of dietary homocysteine on copper status in rats. J Nutr 1990; 120: 1068-74.
43. Rajesh M, Sulochana KN, Coral K, et al. Determination of carbonyl group content in plasma proteins as a useful marker to assess impairment in antioxidant defense in patients with Eales' disease. Indian J Ophthalmol 2004; 52: 139-44.
44. Rajesh M, Sulochana KN, Punitham R, Biswas J, Lakshmi S and Ramakrishnan S. Involvement of oxidative and nitrosative stress in promoting retinal vasculitis in patients with Eales' disease. Clin Biochem 2003; 36: 377-85.
45. Coral K, Angayarkanni N, Madhavan J, et al. Lysyl oxidase activity in the ocular tissues and the role of LOX in proliferative diabetic retinopathy and rhegmatogenous retinal detachment. Invest Ophthalmol Vis Sci 2008; 49: 4746-52.
46. Tamura T and Turnlund JR. Effect of long-term, highcopper intake on the concentrations of plasma homocysteine and B vitamins in young men. Nutrition 2004; 20: 757-9.
47. Bharathi Devi SR, Suganeswari G, Sharma T, Thennarasu M and Angayarkanni N. Homocysteine induces oxidative stress in young adult central retinal vein occlusion. Br J Ophthalmol 2012; 96: 1122-6.
48. Ramakrishnan S, Sulochana KN, Lakshmi S, Selvi R and Angayarkanni N. Biochemistry of homocysteine in health and diseases. Indian J Biochem Biophys 2006; 43: 275-83.